key: cord-0321847-tbx0ppu8
authors: Bauch, Angela; Pellet, Johann; Schleicher, Tina; Yu, Xiao; Gelemanović, Andrea; Cristella, Cosimo; Fraaij, Pieter L.; Polasek, Ozren; Auffray, Charles; Maier, Dieter; Koopmans, Marion; de Jong, Menno D.
title: Informing epidemic (research) responses in a timely fashion by knowledge management - a Zika virus use case
date: 2020-04-18
journal: bioRxiv
DOI: 10.1101/2020.04.17.044743
sha: 7adfd2564c44a8e608f7da414db96e6c1e0a3aaa
doc_id: 321847
cord_uid: tbx0ppu8

The response of pathophysiological research to emerging epidemics often occurs after the epidemic and, as a consequence, has little to no impact on improving patient outcomes or on developing high-quality evidence to inform clinical management strategies during the epidemic. Rapid and informed guidance of epidemic (research) responses to severe infectious disease outbreaks requires quick compilation and integration of existing pathophysiological knowledge. As a case study we chose the Zika virus (ZIKV) outbreak that started in 2015 to develop a proof-of-concept knowledge repository. To extract data from available sources and build a computationally tractable and comprehensive molecular interaction map we applied generic knowledge management software for literature mining, expert knowledge curation, data integration, reporting and visualisation. A multi-disciplinary team of experts, including clinicians, virologists, bioinformaticians and knowledge management specialists, followed a pre-defined workflow for rapid integration and evaluation of available evidence. While conventional approaches usually require months to comb through the existing literature, the initial ZIKV KnowledgeBase (ZIKA KB) was completed within a few weeks. Recently we updated the ZIKA KB with additional curated data from the large amount of literature published since 2016 and made it publicly available through a web interface together with a step-by-step guide to ensure reproducibility of the described use case (S4). In addition, a detailed online user manual is provided to enable the ZIKV research community to generate hypotheses, share knowledge, identify knowledge gaps, and interactively explore and interpret data (S5). A workflow for rapid response during outbreaks was generated, validated and refined and is also made available. The process described here can be used for timely structuring of pathophysiological knowledge for future threats. The resulting structured biological knowledge is a helpful tool for computational data analysis and generation of predictive models and opens new avenues for infectious disease research. Availability www.zikaknowledgebase.eu Funding European Commission’s Seventh Framework Research Programme project PREPARE (FP7-Health n°602525) and ZIKALLIANCE (MK, H2020; No 734548). Author summary During the recent ZIKV outbreak there was little information about the interactions between Zika virus and the host, however, the massive research response lead to a steep increase in the number of relevant publications within a very short period of time. At the time, there was no structured and comprehensive database available for integrated molecular and physiological data and knowledge about ZIKV infection. Researchers had to manually review the literature (amounting to over 5000 articles on ZIKV during our last update of the ZIKA KB in September 2018) to extract information about host–pathogen interaction and affected molecular, cellular and organ pathways. We explored the use of automated literature analysis and a defined cooperative effort between experts from various scientific, biomedical and information-technology domains to rapidly compile existing pathophysiological knowledge as a potential tool to support investigations during an emergency. This tool is contrasted with conventional approaches that would take months to comb through the massive amount of existing literature. In addition to providing background information for research, scientific publications can be processed to transform textual information into complex networks, which can be integrated with existing knowledge resources to suggest novel hypotheses that potentially contribute to innovative infectious disease research approaches. This study shows that the knowledge extraction and mapping process required to inform clinical and research responses to an emerging epidemic can be efficiently and effectively executed with a dedicated and trained group of experts, a validated process and the necessary tools. Our results further provide an overview of ZIKV biology, allow prediction of drug efficacy and indentify specific host factors and signalling pathways affected by ZIKV.

The response to a (re-)emerging infectious disease (ID) epidemic requires a rapid 87 compilation of existing pathophysiological knowledge to inform research priorities 88 guiding basic and clinical research. Gaps in understanding of the underlying 89 mechanisms make it difficult to design effective disease-modifying therapies. Hence, 90

during an emerging ID outbreak, the available information at the time of its 91 emergence and the subsequent rapid accumulation of scientific knowledge from 92 various sources needs to be captured and analysed in a timely and comprehensive 93 fashion. Responding to an ID outbreak therefore would benefit from the use of a 94 knowledge repository that organizes the disease-related knowledge into pathway, 95 molecular interaction and disease maps. Such maps are a relatively new concept 96 that have been used in neurodegenerative and heart diseases (1,2), but which have 97 compounds and diseases (for instance "activates", "restricts", "targets"). To optimise 220 recall and specificity of the mining, we extended the dictionaries for viral names, 221 acronyms and interaction predicates as well as defined a black-list of acronyms 222 causing mostly false positives. The term "microcephaly" is a reusable scientific concept that participates not just in 230 one "Subject-Predicate-Object" construct detected, but in all such constructs 231 detected that mention " microcephaly". Supplementary information is associated with 232 the "microcephaly" object, including, for example, information from the Disease 233 ontology, and other integrated resources, such as Gene-Disease-Association data 234 (DisGeNET). This expandable set of relationships forms a large network of 235 knowledge that enables new knowledge to be inferred by "reasoning" based on the 236 logic encoded in those relationships. 237 238 Finally, the extracted relationships can be curated to manually optimise quality and 239 information content. A curation user interface was implemented to enable the expert 240 team to support or refute the automatically generated relationships. At least two 241 independent researchers (the "4-eye review mode") manually evaluated the 242 evidence for every extracted relationship. In the case that the evaluations from the 243 two researchers conflicted, the conflicts were either resolved during the weekly 244 online conferences or were excluded, as our goal was to maximise specificity 245 (correctness) rather than sensitivity (completeness) of the integrated information. 246

In addition, experts could expand the network with any relevant supporting evidence 247 from other integrated sources, such as public or proprietary databases and 248 experimental data. Semantic mapping describes the process of identifying and linking concepts that are 252 shared between two information sources. We integrated the databases listed in 253 Table 1 using existing concepts such as genes, pathogens or diseases which were 254 identified by ontological descriptors. Semantically identical objects are mapped to 255 descriptive data from literature and databases to allow informed and efficient 256

querying of the overall collected information (e.g. "Dengue disease" is mapped to the 257 following synonyms: "Breakbone fever", "Dengue disorder", "Dengue fever" and 258 "Dengue") (25). To this end, mapping scripts are created to resolve a given input 259 data format and match the provided entity identifiers or ontology terms. Experimental 260 data from key publications is mapped by the same approach. While these data are 261 henceforth available for search and reporting they are not yet displayed as part of 262 any specific molecular interaction and disease map. s  t  a  n  d  a  r  d  i  z  e  d  v  o  c  a  b  u  l  a  r  y  o  f   p  h  e  n  o  t  y  p  i  c  a  b  n  o  r  m  a  l  i  t  i  e  s   i  n  h  u  m  a  n  d  i  s  e  a  s  e  1  1  5  9  2  2  0  1 

To help the expert team establish a specific molecular interaction and disease map 268 we defined a number of queries to explore the collective knowledge. These queries 269 were used, for example, to find diseases and genes associated with a virus of 270 interest to find diseases associated with genes prioritized according to experimental 271

Based on these queries we developed a streamlined, wizard-based user interface to 

To make the results of our internal test case generally available and to support ZIKV 282 research, we provide and maintain a regularly updated ZIKA KB at the following URL 283 www.zikaknowledgebase.eu. As we continue to extend this resource user 284 registration for access will be implemented to ensure the knowledge base is used for 285 research only. 286 287

The data model implemented to provide a semantic representation of ZIKV infection 291 is described in detail in supplemental Figure S2 . Briefly, the model focuses on 292 genes, diseases, pathogens and drugs, and distinguishes between associations 293 derived from literature mining and those provided by experimental data such as 294

Text mining results 296

We searched PubMed with the terms "Zika virus", "Dengue", "West Nile virus", 297 "Japanese encephalitis virus", "Tick-borne encephalitis virus", "Microcephaly" and 298 processing algorithm was applied to these sets of documents to efficiently extract the 308 fast growing information in the biomedical literature. The text mining extracted a total 309 of 11916 relationships, which were manually evaluated to 2982 verified relationships 310 (Table 2 ). The distribution of the curated relationships is depicted in Fig 3, (Table 1) 

large-scale data sets, including microarray gene expression (26,27), RNAseq (28) as 329 well as CRISPR/Cas data (29), have become publicly available and were integrated 330 to identify host factors that are affected during viral infection. 331

Curated text mining results were used to populate the initial ZIKV molecular 333 interaction and disease map. In a second step the map was extended with 334 interaction data (PPI & protein-drug interaction by applying, a network search to 335 implement the breadth-first algorithm (30) which connected genes extracted from text 336 mining relationships based on the overall network. This set of interaction data can be 337 filtered and explored interactively. In a systems medicine approach, a 338 multidisciplinary expert team systematically analysed literature, public databases and 339 experimental resources to create a formal, structured model of molecular and cellular 340 ZIKV-host interactions ("molecular interaction and disease map") 341

After an assessment period of internal use, a web-browser based user interface was 343 implemented to make the PREPARE ZIKA KB available to all ZIKV researchers. By 344 openly sharing the collected data and information, the ZIKA KB allows researchers to 345 generate hypotheses, identify knowledge gaps and interactively explore and interpret 346 data. All data are currently in the public domain. Upon request, data submission can 347 be modified to allow registered users to specify that submitted data should not be 348 publicly available 349

. 350

In the following we provide several example use cases. For instance, publicly 352 available interaction data, such as the PPI and protein-drug interaction data can be 353 used to visualize drug targets and host factors involved in ZIKV pathogenesis. 354

Alternatively, users can filter for PPIs whose source or target is a drug or refine 355 search results to include only proteins localized to a specific cellular compartment, 356 such as the endoplasmic reticulum. The returned networks can be interrogated 357 subsequently to identify host factors that are targeted by the virus and to search for 358 drugs that interact with these host factors. and thus might contribute to drug 359 repositioning for future treatment options for ZIKV infection. The maps can also be 360 explored further by using integrated expression and knockout data. 361

To explore the integrated literature knowledge for relevance or obtain an overview of 362 drug targets or identify critical genes within the network consisting of gene-disease-363 pathogen relationships, predefined perspectives were overlaid onto the default map. 364

The association of ZIKV with microcephaly was reported most frequently across all 365 ZIKV literature and this association is visualized by the thickness of the edges (Fig  366   4A ). Known drug targets interacting directly with ZIKV or microcephaly were 367 highlighted in green for potential intervention evaluation (Fig 4B) . Genes playing a 368 role in ZIKV infected human neural progenitor cells (hNPCs) were also highlighted 369 for comparative analyses of complementary experimental analyses (Fig 4C) . represents the corresponding primary manifestation of these viral infections. 387

Encephalitis is equally frequently associated with ZIKV and DENV confirming that 388 ZIKV is also an aetiological agent in encephalitis. these compounds provide a resource to study ZIKV pathogenesis and can contribute 405 to insights into the biology of ZIKV. To this end, the ZIKV molecular interaction and 406 disease map described in Figure 4 was extended and filtered to include these 407 potential "ZIKV effective drugs" which were connected to genes associated to ZIKV 408 through PPIs (Fig 6) . After this extension ten of the identified ZIKV effective drugs 409 were part of the new map which we then used to gain insight into potential drug 410 mechanisms and ZIKV biology. One of the drugs, Bortezomib, is a known antiviral 411 compound that inhibits replication of flaviviruses (32). Bortezomib is a proteasome 412 inhibitor, suggesting that proteasome action is essential for ZIKV replication. This genes whose expression is affected during ZIKV infection indicated that Sorafenib 534 likely acts via its target genes, FLT3 and/or BRAF, but not via its alternative target 535 genes VEGFR or PDGFR. In addition, the number of drugs to be screened was 536 reduced from 774 to 64 by filtering potential drug candidates based on their network 537 distance to ZIKV infection associated genes and additional phenotype relevant 538 additional knowledge, such as contained in the "FDA pregnancy" label. 539

The conclusions that can be drawn are limited by the initially low number of available 541 publications and limited experimental data, a situation which is inherent to most 542 emerging epidemics. Nevertheless, the work presented shows that the use of a 543

knowledge integrating system can provide guidance for clinical and research 544 responses, such as follow-up studies regarding the association between ZIKV, 545 microcephaly and epilepsy, the validation of candidate drugs for ZIKV treatment, and 546 the validation of candidate genes in specific functional assays to better understand 547 molecular ZIKV infection mechanisms. or to complement existing functional genomic 548 approaches with proteomics studies, such as the integrated proteomics approach 549 identifying cellular targets of ZIKV proteins (38,39). These studies allow additional 550 comparative analyses between ZIKV and other flavivirus family members in terms of 551 virulence and pathogenic traits. 552

Another limitation of the system is the restricted types of information which can be 553 retrieved by text mining. While qualitative associations between genes/proteins, 554 drugs, diseases and organisms are readily amendable to automatic approaches, it is 555 currently almost impossible to extract, for example, clinical study designs, detailed 556 quantitative information or complex treatment plans. 557

Finally, the ZIKA KB in its current stage enables exploration of the integrated 558 information, as well as generation and curation of text-mining analysis but is not a 559 public tool for molecular interaction and disease map generation. The functions 560 required for these tasks will need further refinement before they can be made 561 available in a general way. 562

In summary, this approach in our opinion, provides a feasible way to collect and 564 integrate existing knowledge to better understand the molecular mechanisms of an 565 emerging pathogen. In addition our approach helps to identify gaps in knowledge 566

and, together with the other features, guides rapid and effective responses to future 567 epidemics. We have made the specific outcome of our approach, the Zika 568

KnowledgeBase, publicly available as a hopefully valuable resource to the ZIKV 569 research community. 570

In the light of the current COVID-19 pandemic we now apply the described workflow 571

to SARS-CoV-2 and other coronaviruses and will make the developed resource 572 available as described. 573 574 575

Integrating pathways of Parkinson's disease in a molecular interaction map

CARFMAP: A Curated Pathway Map of Cardiac Fibroblasts

Response of the mosquito protein 588 interaction network to dengue infection

Flavivirus NS3 and NS5 proteins interaction network: a 591 high-throughput yeast two-hybrid screen

A 593 comprehensive map of the influenza A virus replication cycle

The Emergence of Zika Virus: A Narrative 596

The emergence of Zika virus and its new clinical 598 syndromes

Zika Virus Pathogenesis: From Early Case Reports to 600

Zika virus: an 602 emerging challenge to public health worldwide

Understanding Zika virus

Epidemiology and neurological complications of infection by the 606 Zika virus: a new emerging neurotropic virus

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses 610

of Studies That Evaluate Health Care Interventions: Explanation and 611

Elaboration

An Experimental Application of the Delphi Method to the 615 use of experts

Ovarian cancer 617 biomarkers for molecular biosensors and translational medicine

Semantic data integration and knowledge management 621 to represent biological network associations

Knowledge 625 management for systems biology a general and visually driven framework 626 applied to translational medicine

The COPD Knowledge Base: enabling data analysis and computational 630 simulation in translational COPD research

ChEBI: a database and ontology for chemical entities of biological interest

The international conference for the tenth revision of the International 639

Classification of Diseases. Strengthening of Epidemiological and Statistical 640

World Health Organization

Knowledge 643

Networks of Biological and Medical Data: An Exhaustive and Flexible Solution 644 to Model Life Science Domains

Disease Ontology: a backbone for disease semantic integration

NCI Thesaurus: 652 using science-based terminology to integrate cancer research results

LIGAND: chemical database for enzyme 659 reactions

Knowledge 662 management for systems biology a general and visually driven framework 663 applied to translational medicine

Dynamic 665 changes in global microRNAome and transcriptome reveal complex miRNA-666 mRNA regulated host response to Japanese Encephalitis Virus in microglial 667 cells. Sci Rep

Expression Analysis Highlights AXL as a Candidate Zika Virus 670

Entry Receptor in Neural Stem Cells

Human Cortical Neural Progenitors and Attenuates Their Growth

A 675 CRISPR screen defines a signal peptide processing pathway required by 676 flaviviruses

The shortest path through a maze

International Symposium on the Theory of Switching

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus 682

Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection

The EGF receptor family: spearheading a merger of 687 signaling and therapeutics

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling

Host Microbe

Cochrane Handbook for Systematic 692

Reviews of Interventions

Development of evidence-based clinical 695 practice guidelines (CPGs): comparing approaches

ChainRank, a chain prioritisation method for contextualisation of biological 700 networks

An orthogonal proteomic survey uncovers novel Zika virus host factors

Chasing Intracellular Zika Virus Using 705

Based on input from clinical and virology experts the concepts required to represent 716 existing pathophysiological knowledge of infectious diseases were modelled using 717 the BioXM Knowledge management environment

are defined on an abstract level such as "gene", "disease" 719 or "interacts with". For the ZIKV KB we focused on concepts required to represent 720 text mining results and information from structured databases of protein-protein and 721 drug -protein interaction

Pathogens are displayed as yellow nodes and were uniquely identified by using the 723

The authors wish to thank their colleagues for discussion and feedback, and 577Sheridon Sauer and Shannon Frances for critical review of the article. 578 579

human embryonic cortical neural progenitor cells (Fig 7) . These genes can serve as 421an entry point to be tested in specific assays designed to unravel molecular 422 mechanisms between of ZIKV involvement in microcephaly. 423Another predicted ZIKV effective drug is Sorafenib, a multi-target tyrosine kinase 424inhibitor. The ZIKV map was used to identify the effective target of Sorafenib: 4251. Sorafenib interacts with 4 target genes, FLT3, BRAF, VEGFR (also known as 426 KDR) and PDGFR. The latter two genes are known to interact with additional drugs, 427 such as Sunitinib, Pazopanib, Dasatinib and Imatinib. These additional drugs were 428 among those which had no effect in the ZIKV infection assay. 429 2. In ZIKV infection expression data, none of the genes producing protein products 430 that interact with VEGFR and PDGFR through known PPI (orange edges) with ZIKV 431 are differentially expressed (Fig 8) . In contrast, BRAF and SOCS2, a FLT3 432 interactor, were unregulated upon ZIKV infection. 433Based on the observations above drawn from the ZIKV map, we hypothesise that 434 FLT3 or BRAF are the effective targets of Sorafenib in ZIKV infection, rather than 435 VEGFR and PDGFR. This exemplifies how molecular interaction and disease maps 436can be used to provide further insight into ZIKV biology. The network analysis described above could also be used to rank drugs according to 462 their distance to known ZIKV associated genes, such as STAT2, to suggest a metric 463 for priorisation in screening assays (34). The discussed extended ZIKV map contains 464 429 target gene products that interact with FDA approved drugs. Evaluation of the 465 distance between STAT2 and drug targets via experimentally proven PPIs revealed 466 that targets of ZIKV effective drugs were on average more proximal to STAT2 467 compared to other targets. 468Combining the proximity measure with additional knowledge, for example the "FDA 469 pregnancy" label, reduces the number of drugs to be screened from 774 to 64. pathogenesis. In addition to interactive exploration, a corresponding ranking of 516 connections in a network based on integration of multiple pieces of biological 517 evidence can also be performed systematically and on a large scale, for example, by 518 applying the ChainRank method (37) , which we plan to integrate in the future. 519 520 NCBI Taxonomy ontology. Compounds (white nodes) were referenced to entries of 724 the ChEBI ontology. Diseases (violet nodes) and genes (orange nodes) can 725 reference one or multiple sources such as ICD10, Entrez or Ensembl. Relationships 726 between pathogens, genes, drugs and compounds were defined by three types of 727 text mining relations, upregulation (green edges), downregulation (red edges) and 728 regulation (black edges). Associated information, not represented as object or 729 relation, is being stored as so called "annotation" basically a note that can be 730 assigned to any semantic concept. The annotation form "Textmining information 731 evidence", for example, stores information, such as the sentence containing the 732 extracted statement (field "Reference") or the predicate (field "Interaction type") and 733 links directly to the PubMed entry (represented as BioRS entry: MEDLINE). To 734 enable experts to support or contradict extracted text mining relationships the 735 annotation form "Textmining Validation" was introduced to generate a configurable 736 curation workflow. Molecular interaction and disease maps are modelled using the 737 "context" object type to group specific sub-networks (interactions between genes, 738 diseases, pathogens and drugs) within the global semantic network. PPI and drug-739 protein interactions are represented by the "Interaction" relation (orange edges) with 740 supportive evidence stored in two annotation forms ("BioGRID Interaction Evidence" 741 and "Interaction Information" storing information from the VirHostNet database), and 742can be added as additional sub-networks to a disease map. 743Based on the data model dynamic visualisation can be generated, for example drug 744 targets or differentially expressed genes based on configurable queries and views. 745The data model is automatically transformed into a natural language like query and 746reporting language. This language can be used to e.g. define a query retrieving the 747 number of drugs that interact with a protein of interest, and generating a view which 748 35 applies a colour code to a gene according to the number of interacting drugs.